Thermo Fisher Scientific Inc.
TMO
$492.60
$3.110.64%
NYSE
| 06/28/2025 | 03/29/2025 | 12/31/2024 | 09/28/2024 | 06/29/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.97% | 0.18% | 4.68% | 0.23% | -1.37% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.98% | 0.18% | 4.68% | 0.23% | -1.37% |
| Cost of Revenue | 3.99% | -0.11% | 1.24% | 0.27% | -3.49% |
| Gross Profit | 1.54% | 0.62% | 9.72% | 0.16% | 1.83% |
| SG&A Expenses | -2.30% | -4.62% | 3.96% | 2.06% | 1.68% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | 2,900.00% | -- | -- |
| Total Operating Expenses | 2.41% | -1.11% | 2.69% | 1.00% | -2.18% |
| Operating Income | 5.67% | 6.67% | 13.56% | -3.14% | 2.69% |
| Income Before Tax | 1.72% | -0.43% | 13.51% | -1.09% | 18.95% |
| Income Tax Expenses | -28.13% | -66.19% | 12.78% | 86.79% | 146.15% |
| Earnings from Continuing Operations | 4.18% | 13.44% | 13.57% | -3.83% | 14.10% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 66.67% | 0.00% | -75.00% | -- | -500.00% |
| Net Income | 4.46% | 13.48% | 12.27% | -4.96% | 13.74% |
| EBIT | 5.67% | 6.67% | 13.56% | -3.14% | 2.69% |
| EBITDA | -0.04% | -0.62% | 6.29% | -6.40% | -0.61% |
| EPS Basic | 5.56% | 14.68% | 13.74% | -3.96% | 14.93% |
| Normalized Basic EPS | 9.00% | 4.90% | 16.60% | -2.88% | 5.16% |
| EPS Diluted | 5.89% | 15.03% | 13.81% | -3.85% | 15.10% |
| Normalized Diluted EPS | 9.28% | 5.17% | 16.60% | -2.88% | 5.43% |
| Average Basic Shares Outstanding | -1.05% | -1.05% | -1.29% | -1.04% | -1.04% |
| Average Diluted Shares Outstanding | -1.31% | -1.30% | -1.29% | -1.03% | -1.29% |
| Dividend Per Share | 10.26% | 10.26% | 11.43% | 11.43% | 11.43% |
| Payout Ratio | 0.04% | -0.03% | -0.02% | 0.17% | -0.03% |